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Abstract 
 
Adolescents appear to be uniquely vulnerable to nicotine and its reinforcing effects which 
contributes its addictive potential (Levin et al., 2007). Additionally, chronic adolescent nicotine 
exposure may cause long-term changes in the brain pathways that mediate anxiety (Slawecki et 
al., 2003). The Bed Nucleus of the Stria Terminalis (BNST) has been suggested as part of the 
anxiety pathway (Walker & Davis, 2009) and has been implicated in one animal model of 
anxiety known as the Light Enhanced Startle Effect (LES). The research question this thesis 
addressed was: Will adolescent nicotine exposure cause long-lasting changes in anxiety that 
persist into adulthood? Based on existing literature, we hypothesized that exposing adolescent 
rats to nicotine would cause a change in anxiety behavior measured in LES when the animals 
were later tested as adults. Adolescent Sprague-Dawley rats were exposed to either nicotine (.15 
mg/kg, .40 mg/kg) or saline from postnatal days 28-42. On approximately postnatal day 67 in 
early adulthood, the effect of earlier adolescent nicotine exposure on anxiety was assessed in the 
light-enhanced startle paradigm. Adult males exposed to nicotine as adolescents showed 
significant increases in anxiety measured in LES compared to saline controls. Conversely, adult 
females showed no significant changes in anxiety behavior as a result of prior adolescent 
nicotine exposure. These findings suggest nicotine exposure during adolescence can produce 
long-lasting changes in the neural pathways that mediate anxiety that persist into adulthood. 
Differential development of the BNST in males versus females, particularly in terms of nicotinic 
acetylcholine receptor density, is considered as one explanation for the observed sex differences. 
The possibility that nicotine may differentially affect anxiety measured in reflexive versus 
volitional (choice-based) response measures is also discussed in relation to how current findings 
may be integrated with existing literature. 
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Effect of Chronic Adolescent Nicotine Exposure on Anxiety in Adulthood 
 
 According to the Center for Disease Control (2011), tobacco is the leading cause of 
preventable death in the United States. Despite efforts to educate adolescents about tobacco’s 
harmful effects, smoking patterns in young adults have risen (Lantz, 2003). The Campaign for 
Tobacco Free Kids (2013) suggests that over 80% of adult smokers began smoking before 18 
years of age. Adolescents have higher responsiveness to incentives and reward, which is 
correlated to increased dopamine activity in the nucleus accumbens, a brain structure linked to 
reinforcement and addiction (Ernst et al., 2006). In animals, adolescent rats self-administer more 
nicotine than their adult counterparts (Levin et al., 2007), suggesting adolescents are more 
vulnerable to the reinforcement effects of nicotine and therefore dependence. Adolescents also 
have weak harm-avoidance and inhibition systems, correlated to age-specific alternations in 
amygdala and medial/ventral prefrontal cortex activity, respectively (Ernst et al., 2006). These 
neural alterations may be linked to a disregard for one’s health, increased risk taking and novelty 
seeking behavior, and problems with impulse control characteristic of the adolescent period. 
 There is an additional relationship between nicotine exposure in adolescence and the 
emergence of anxiety and depression-like symptoms in adulthood (Slawecki et al., 2003; Iniguez 
et al., 2009; Trauth et al., 2000) indicating that smoking patterns that initiate in adolescence may 
have serious long-term psychiatric implications. In particular, it is well known that adolescence 
is an important period for the development of neural pathways that mediate anxiety (Spear, 
2000). Since anxiety is the most common condition in psychiatric disorders (Kessler et al. 1994), 
the role of chronic adolescent nicotine exposure to the anxiety pathway is of particular 
importance.  
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Adolescent nicotine exposure may be critical in altering the development of the anxiety 
pathway. Throughout the brain, cholinergic receptors known as nicotinic acetylcholine receptors, 
or nAChRs, respond to nicotine as well as to endogenous acetylcholine. NAChRs, especially 
α4β2 subtypes, are implicated in the anxiety pathway in both people and animals. Research by 
Roni and Rahman (2011) indicate antagonists for nAChRs, such as the α4β2 antagonist lobeline, 
have anxiolytic effects in animals. Roni and Rahman (2011) exposed mice to lobeline at 7-8 
weeks of age and then tested them in the elevated plus maze, or EPM.  The EPM is an animal 
model of anxiety in which rodents traverse “open” versus “closed” arms of a simple plus maze. 
Bright and open spaces are naturally aversive to rodents. Increased time in the open arms or 
increased number of open arm entries indicates a decreased state of anxiety. Mice injected with 
.04 mg/kg lobeline prior to EPM testing, spent more time in the open arms and made more open 
arm entries compared to the saline-exposed control (Roni & Rahman, 2011) indicating α4β2  
receptors may play an important role in anxiety expression. Nicotine, therefore, a potent and 
common agonist of the α4β2  receptor, has the potential to affect anxiety.  
 Literature concerning nicotine’s role in anxiety is mixed. Some studies suggest that acute 
nicotine can have an anxiolytic effect in the short term (Cao et al., 1993; Brioni et al., 1994). 
Nicotine’s capacity to reduce anxiety is consistent with the idea that smoking one cigarette can 
produce a relaxing effect (Parrott, 1999). However, this idea has been countered by evidence 
suggesting the decrease in anxiety reported after nicotine intake is actually due to a nicotine-
induced reduction in the negative effects of nicotine depletion which occur over a period of 
smoke-free abstinence. That is, nicotine may not be anxiolytic per se but may decrease negative 
symptoms of withdrawal leading to the perception that smoking can reduce stress (Parrott, 1999). 
Other studies indicate that acute nicotine may be anxiogenic (Ouagazzal et al., 1999; File et al., 
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1998). File et al. (1998) suggest that acute nicotine’s effects may be dependent on both dose and 
brain region and are not universally anxiogenic or anxiolytic. The uncertainty over acute 
nicotine’s effects on the anxiety pathway is likely due to the ubiquity of nAChRs throughout the 
brain. There are also different nAChR subtypes (e.g., α4β2 , α7) which may cause different 
downstream effects when activated or inactivated, and activation of different receptor subtypes 
may depend on dose of nicotine exposure (Wonnacott,1997). Differential effects of nicotine that 
depend on different brain regions are probably due to the fact that different brain regions have 
unique densities of specific receptor subtypes. (Wonnacott,1997) 
Because it is unclear whether acute nicotine is anxiogenic (Ouagazzal et al., 1999; File et 
al., 1998) or anxiolytic (Cao et al., 1993; Brioni et al., 1994), evidence from acute nicotine’s 
effects cannot be used to postulate its effects in chronic use. As such, it is critical to study the 
effects of long-term nicotine use on the anxiety pathway, and particularly during adolescence, a 
period of growth and structural remodeling in the brain (Smith, 2000). Davis and Shi (1999) 
demonstrated a crucial role of the Bed Nucleus of the Stria Terminalis of the Amygdala (BNST), 
in anxiety, in rodents using the Light Enhanced Startle (LES) paradigm. The LES paradigm takes 
advantage of the fact that rats are nocturnal and find bright light aversive, presumably due to 
enhanced risk of predation in bright (e.g. open field) vs. dark (e.g. burrow) situations (Walker & 
Davis, 1997). Walker and Davis (1997) demonstrated that startle reactions elicited by loud noises 
in the presence of a bright light were enhanced compared to startle reactions to the same noise 
stimuli under dark conditions. This is the light-enhanced startle effect. Light-enhanced startle 
assesses anxiety in a reflexively elicited response measure (i.e., startle). This feature of the LES 
paradigm will be further discussed later. Importantly, Davis and Shi (1999) found that startle 
amplitude in the anxiety-eliciting bright condition was reduced after inactivating the BNST with 
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a glutamate antagonist, NBQX. These findings imply that the BNST is involved in the 
expression of anxiety (Davis & Shi 1999). 
Adolescent animals appear to be especially vulnerable to the long-term neurobiological 
effects of nicotine. An increase in receptor density is one manner in which the nervous system 
can become more sensitive to a ligand. Abreu-Villaca et al. (2004) reported that adolescent 
nicotine exposure in rats causes a robust upregulation of nAChRs in the midbrain that was long 
lasting. To the extent nicotine is anxiogenic, this outcome could be taken to imply that an 
individual who smokes tobacco in adolescence may be more likely to develop anxiety-like 
symptoms in adulthood. 
Some research is consistent with this possibility. Slawecki et al. (2003) applied nicotine 
via transdermal patches to male adolescent rats. The animals were tested two to three weeks later 
in young adulthood in the open field paradigm. In the open field paradigm, a rat is placed in the 
center of a chamber with an open top and walls too high to escape. The latency to exit the center 
and move to the perimeter of the field and the number of perimeter and center square entries, are 
measured. Less time spent in the center of the open field and less overall movement is indicative 
of anxiety. Slawecki et al. (2003) found that animals exposed to nicotine as adolescents had a 
lower latency to escape to the perimeter, as well as fewer square crossings, indicating increased 
anxiety in a potentially dangerous, novel environment in which they could be evolutionarily 
vulnerable to predation. This is an important observation because it suggests that exposure to 
nicotine in adolescence can cause changes in anxiety behavior that persist into adulthood (see 
also Trauth et al., 2000). Smith et al. (2006) further observed that rats exposed to nicotine in 
adulthood as opposed to adolescence did not show similar alterations in anxiety behavior. The 
outcome of these experiments suggest that adolescent nicotine exposure can have a significant 
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and potentially long-lasting impact on the neural anxiety pathway in adulthood.  Moreover, this 
impact may be attributable to nicotine’s effect on the development of the anxiety pathway 
because adolescent but not adult exposure has been shown to alter anxiety behavior. 
Existing literature implies that chronic adolescent nicotine exposure may durably alter the 
neural anxiety pathway. While some studies have supported this (Slawecki et al., 2003; Smith et 
al., 2006; Trauth et al., 2000), these studies have measured anxiety in paradigms that require 
voluntary, non-reflexive, behavior (i.e., a rat choosing to move from one location to another in 
the Open Field test or EPM). The Light Enhanced Startle paradigm measures changes in the rat’s 
acoustic startle reflex and therefore permits assessment of how nicotine affects anxiety in a 
reflexive as opposed to voluntary response measure. Currently there are no published studies that 
examine the long-term effects of adolescent nicotine exposure on anxiety measured in LES.  
Because response systems that engage reflexive versus voluntary behavior may be mediated by 
different brain structures, and affected by anxiety in unique ways, the present research sought to 
address this gap in the literature by examining the impact of chronic adolescent nicotine 
exposure on anxiety measured in the LES paradigm.  
Research Hypothesis and Predictions 
The research question this thesis addressed was: Will adolescent nicotine exposure cause 
long-lasting changes in anxiety that persist into adulthood?  We hypothesized that exposing 
adolescent rats to nicotine would cause a change in anxiety behavior measured in LES when the 
animals were later tested as adults. Sprague-Dawley rats were exposed to nicotine for 15 
consecutive days during adolescence. Following a long period of abstinence, which extended 
beyond withdrawal and into adulthood, animals were tested in the LES paradigm, modeled after 
procedures previously established in literature (Walker & Davis, 1997). Literature reviewed 
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above suggests that nicotine exposure can alter the density of midbrain nAChRs, which are 
themselves linked to anxiety (Abreu-Villaca et al., 2004). Findings from behavioral studies 
further suggest that adolescent nicotine can produce durable changes in anxiety behavior 
measured in paradigms such as the open field (Slawecki et al., 2003; Trauth et al., 2000; Smith et 
al., 2006). The core prediction of the present research is that adolescent nicotine exposure will 
produce changes in anxiety that persist into adulthood measured in the LES paradigm. Support 
for this prediction would imply that chronic adolescent nicotine exposure causes persistent 
developmental changes in the brain pathways that mediate anxiety.  
Method 
Subjects  
Fifty-one Sprague-Dawley (25 male and 26 female) rats were obtained from the breeding 
colony of the Department of Psychology at The College of William & Mary. Animals were 
weaned on PD21 and housed individually in hanging wire-mesh cages. Rats were under a 14 
hr/10 hr light-dark cycle and had access to food and water ad libitum. Animal care was carried 
out in accordance with approved IACUC protocols. 
Apparatus	  
Light-enhanced startle testing occurred in three identical small startle cages. The startle 
cages served as functional restraint cages (Coulbourn Instruments, Model E05-20) which were 
themselves placed inside larger sound and light-attenuating startle chambers (Coulbourn 
Instruments, Model E10-24). The sides and bottom of each startle cage were constructed of flat 
black plastic, and the lid of each cage consisted of a rounded convex steel-bar grate that could be 
clasped to the frame of the cage. Startle cages measured 18.5 cm x 11cm x 9.5 cm (height 
measured from base of plastic floor to top of convex lid). Each startle cage could be placed 
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inside its own larger startle chamber such that animals could be trained and tested individually. 
The startle chamber consisted of a wooden box lined with sound-attenuating acoustic foam 
padding and the interior of the chamber measured 52 cm X 52cm X 30.5 cm (L x W x H). The 
center of each chamber lid housed a 7.5 cm high-frequency speaker that could deliver a 50-ms 
burst of white noise (rise time 0 ms) that served as the stimulus to elicit startle reactions. The 
amplitude of startle stimuli delivered by the speaker was controlled by software and varied 
between 100 dB, 105 dB and 115 dB (C scale). Each startle cage was placed upon a 5-lb 
maximum output transducer platform (Coulbourn Instruments, Model E45-15) located beneath 
the speaker of the chamber lid such that the distance between the speaker and lid of the startle 
cage was 15 cm. Startle reactions to the 50-ms noise bursts were measured by strain gage load 
cells which served as response sensors in the transducer platforms. The transducer recorded 
voltage displacement proportional to the force applied to it and peak voltage displacement 
occurring within the first 200 ms from startle stimulus onset transformed into grams of force 
served as the dependent measure.  
A 26-W, General Electric compact fluorescent light bulb could be turned on to provide 
bright illumination of the chamber (1876 lux, measured from the center of the startle platform). 
The bulb was centered on the left interior wall of the startle chamber and was positioned 19 cm 
from the chamber floor. In this position the bulb was located 30 cm from the center of the startle 
cage which held the animal during sessions. All data recording and stimulus delivery was 
controlled by LabLinc V (Coulbourn Instruments) hardware and software. The light-enhanced 
startle chamber is shown in Figure 1. 
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=================================== 
Insert Figure 1 about here 
===================================	  
Procedure	  
Rats were counterbalanced into 3 experimental groups, with respect to weight, litter, and 
sex. Each group consisted of approximately 18 subjects, with equivalent males and females, as 
possible. The three experimental groups consisted of:  low dose of nicotine (0.15 mg/kg), high 
dose of nicotine (0.40 mg/kg) or vehicle control (saline). Nicotine was nicotine tartrate dissolved 
in saline and titrated to a pH of 7.4. 	  
Nicotine Exposure. Beginning on PD28, and ending on PD42, rats were exposed twice 
daily to intraperitoneal (I.P.) nicotine or saline injections depending on group designation. 
Injections occurred once in the morning (approximately 0830) and once in the early afternoon 
(approximately 1430). Rats were weighed prior to each injection and received 1 ml/kg mixed 
nicotine solution based on body weight. Following the PD28-42 injection series, rats remained in 
home cages in the absence of nicotine creating an abstinence period of 38-39 days, which was 
followed by LES testing.	  
LES Test Procedure. Rats were tested for LES on PD66 or PD67. Each LES test session 
was comprised of two 20-min phases with each phase separated by a 5-minute rest period. 
During Phase 1 rats were placed in the startle chamber and after 600 s were exposed to 30, 50-ms 
startle stimuli, ten at each of three different dB amplitudes (100 dB, 105 dB, 115 dB). The 
interstimulus interval (ISI) between each startle stimulus was 30 s. The distribution of different 
dB startle stimuli was pseudo-randomly distributed such that a given dB startle stimulus could 
occur no more than two times in succession and that the different amplitude startle stimuli 
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occurred in blocks of three (i.e., [115100105], [105115100]). Phase 1 was conducted in 
the dark with no chamber illumination. Following the completion of Phase 1, rats were removed 
from the chambers and exposed to a 5-minute rest period in a separate transport cart.  At the end 
of the 5-minute rest period rats were returned to startle chambers and Phase 2 was initiated. 
Phase 2 was an identical replication of Phase 1 except that Phase 2 was conducted in the 
presence of a bright (26-W compact fluorescent) light. During Phase 2, 30 startle stimuli at each 
of the three different dB amplitudes were presented during the 20-min session. Phase 1 and 
Phase 2 were discriminated only by the absence (Phase 1) or presence (Phase 2) of the bright 
light. For each animal, a mean startle score averaging across Phase 1 trials at each startle pulse 
amplitude and a corresponding mean startle score averaging across Phase 2 trials at each startle 
amplitude was computed.  Comparison of difference scores (Phase 2 mean - Phase 1 mean) was 
used to evaluate differential effects of nicotine on the magnitude of LES.	  
Results 
Raw peak startle data were subjected to preliminary analysis in order to assess the 
presence of the basic LES effect on the test day.  An overall within-subject ANOVA collapsed 
across all over variables (dB amplitude, drug dose, sex ) compared peak startle in Phase 1 versus 
Phase 2.  The analysis revealed a significant main effect of Phase, F(1,50)=64.96, p < .001. As 
shown in Figure 2, peak startle during Phase 2 in the presence of the bright light was higher than 
peak startle during Phase 1 in the dark. This is the light-enhanced startle effect.  Figure 2 also 
shows the computed difference score (Phase 2 mean – Phase 1 mean). 
=================================== 
Insert Figure 2 about here 
=================================== 
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The main difference score data from the LES test were analyzed in a 3 (dB amplitude: 
100, 105, 115) X 3 (Drug: saline, 0.15 mg/kg nicotine, 0.40 mg/kg nicotine) X 2 (Sex: male, 
female) ANCOVA with test box as the covariate. The analysis revealed a significant 3-way dB X 
Drug X Sex interaction, F(4, 88)=2.82, p = .03, and no other main effect or interaction. The 
source of the 3-way interaction appeared to be different patterns of responding across dB 
amplitude and drug doses in males and females (see Figure 3 and Figure 4). This appearance was 
confirmed by dB X Drug interaction contrasts conducted separately on test data from males and 
females. In males, there was a significant dB X Drug interaction, F(4, 42)=3.30, p = .019. As can 
be seen in Figure 3, adolescent males exposed to nicotine generally showed higher levels of 
light-enhanced startle relative to saline controls. In females, there was no dB X Drug interaction, 
F(4, 44)<1, and as suggested by findings illustrated in Figure 4, nicotine failed to have any effect 
on the magnitude of light-enhanced startle in females. 
=================================== 
Insert Figure 3 and Figure 4 about here 
=================================== 
Fisher post-hoc tests (Keppel, 1982) were conducted to evaluate whether adolescent 
nicotine exposure altered the magnitude of LES in adult animals as suggested by data from 
Figure 3. In males: compared to saline controls, significantly higher LES was observed in the 
0.15mg/kg condition for the 100dB startle probe; significantly higher LES was observed in both 
the 0.15 mg/kg and 0.40 mg/kg nicotine conditions relative to saline treated animals in the 105 
dB startle probe condition, and significantly higher LES was observed in the 0.40 mg/kg nicotine 
condition relative to saline controls in the 115 dB startle condition. Because the dB X Drug 
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contrast conducted on data from females failed to reveal any main effect (or interaction as 
previously indicated) no further statistical tests were conducted on data from females. 
Discussion 
 We predicted that adolescent nicotine exposure would produce changes in anxiety that 
persist into adulthood, measured in the LES paradigm. That prediction was supported but 
depended importantly on sex. Adolescent nicotine exposure enhanced anxiety measured in LES 
in males (Figure 3) but not in females (Figure 4) when compared to saline controls. The general 
increase in anxiety behavior following adolescent nicotine exposure is supported by results from 
other studies (Slawecki et al., 2003; Smith et al., 2006; Trauth et al., 2000). The BNST is known 
to play a role in anxiety (Davis et al., 2009). Furthermore, LES which measures anxiety 
modulation of reflexively elicited startle behavior is itself a test in which the BNST has been 
critically implicated (Davis and Shi, 1999). It is likely that alterations in this “reflexive anxiety” 
pathway containing the BNST is responsible for the observed effects of adolescent nicotine on 
LES.  
Nicotine exposure is known to cause nAChR upregulation (Trauth et al., 1999; Nashmi et 
al., 2007), but can also cause down regulation of nAChRs (Changeux, 2010), depending on the 
nAChR subunit and location.  Given the role of nAChRs in some forms of anxiety discussed 
earlier (see Roni & Rahman, 2011), alteration of nAChR density in the anxiety pathway may be 
involved in the pattern of outcomes observed in this experiment. As discussed earlier, 
adolescence is an important period of development for the pathways that mediate anxiety (Spear, 
2000). As a result, chronic exposure to nicotine that occurs during adolescence might be 
expected to have different effects than chronic exposure in adulthood (Caldarone et al., 2008) or 
acute exposure in adolescence (Cheeta et al., 2001). These considerations imply adolescence 
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may be a uniquely vulnerable period for nicotine’s impact on nAChR density in brain systems 
that mediate anxiety. 
 A major finding in this experiment was that anxiety in females appeared to be unaffected 
by adolescent nicotine exposure, in contrast to more apparent effect of nicotine in males. This is  
In the elevated plus maze (EPM), Caldarone et al. (2008) revealed that adult female mice 
exposed to chronic nicotine showed increase in anxiety-like behavior but males did not, a pattern 
opposite to that observed here. Trauth et al. (2000) reported similar findings following chronic 
adolescent nicotine exposure. In the open field paradigm, females demonstrated increased 
anxiety behavior and males showed no change (Trauth et al., 2000). [It should be noted that 
Trauth et al. (2000) exposed animals to nicotine between PD30 and PD47.5, whereas the present 
study did so between PD28 and PD42.] There may be important developmental changes in the 
anxiety pathway in rats between PD28 and PD30 or between PD42 and PD47.5 that could 
potentially account for differences in outcome. Finally, Cheeta et al. (2001) found in the social 
interaction test, in which likelihood of interacting with a novel specific stranger is taken to index 
anxiety, that adolescent female rats were more susceptible to the anxiolytic effect of acute 
nicotine exposure. These studies are not identical in outcome and differ in pattern of nicotine 
dosing (chronic vs. acute) but they nonetheless suggest a strong correlation between effect of 
nicotine on anxiety and sex. Unlike the present findings, they suggest that females are more 
susceptible to the anxiety altering effects of nicotine (see Table 1 for comparison of select 
findings from the literature compared to outcomes of the present experiment).  
=================================== 
Insert Table 1 about here 
=================================== 
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One source for such deviation may be found in comparison of the response systems that 
are required in different models of anxiety. The Elevated Plus Maze, Open Field Test, and Social 
Interaction tests discussed earlier may all be characterized as volitional tests that measure choice 
behavior in which the animal may choose to locomote into or out of different arms of a maze or 
choose an area of the field to enter. The LES paradigm uniquely relies on an involuntary reflex 
(the startle reflex) that does not rely on volition or choice.  Considered this way, findings of the 
present experiment might imply that nicotine’s effect on anxiety modulation is different in 
reflexive versus volitional control systems. 
 Moreover, brain regions mediating “reflexive anxiety” and “volitional anxiety” may 
develop differently in males versus females. The encapsulated region of the BNST is 97% larger 
in adult males when compared to females (Hines et al., 1992). As stated earlier, the BNST is 
crucial in the expression of anxiety measured by LES (Davis et al., 2009). Interestingly, 
inactivation of the BNST does not cause a change in performance, in rats, in the open field 
paradigm (Crestani et al., 2010) but does affect the magnitude of LES (Davis & Shi, 1999). This 
indicates that the BNST may not play a role in anxiety expressed in the open field paradigm. 
Thus, when nicotine alters a pathway that contains the BNST, the effects may be expressed in 
changes in LES, but not the open field.  Because the BNST is physiologically different in males 
and females, nicotine’s effects would be expected to depend on the sex, as was observed in the 
present study. One speculation is that observed sex differences reported here may be due to 
differential receptor density between males and females in the BNST. If this is correct, then 
chronic nicotine exposure might have different effects on upregulation (or downregulation) of 
nAChRs in the BNST in males versus females. 
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Trauth et al. (1999) suggest that nicotine exposure causes an upregulation of nAChRs in 
the cerebral cortex. There are synaptic connections between the cerebral cortex and lateral 
amygdala that are strengthened by nicotine exposure (Huang et al., 2008). This could lead to 
increased activity of the amygdala. Several regions within the amygdala are implicated in the 
anxiety pathway (Davis and Walker, 2009). Therefore, increased activity in the amygdala might 
be expected to increase anxiety levels. Importantly, Trauth et al. (1999) demonstrated that 
adolescent nicotine exposure causes greater upregulation of nAChRs in males compared to 
females. To the extent this occurred as a result of adolescent nicotine exposure in the present 
research, this might be associated with differential enhancement of amygdala activity males. 
Greater enhancement of anxiety pathway activity in males compared to females might lead to the 
expression of enhanced anxiety behavior in males relative to females, as was observed in the 
present experiment.  
Future Directions 
One future direction would be to explore more directly the specific neural alterations that 
mediated behavior effects of adolescent nicotine exposure seen in this research. One direction 
would be to examine to what extent alteration in cortical nAChRs played a role in our findings. 
Site-specific administration of antagonists, that are specific to different nAChR subtypes, and/or 
molecular knockout techniques may provide approaches to better address this issue. By 
administering nAChR antagonists to the regions of the cortex that connect to the lateral 
amygdala, we could effectively suppress any effects of nicotine in that region. If antagonist 
administration prior before every nicotine injection in adolescence eliminates the effect of 
nicotine on anxiety we observed, this would imply that the cortex-lateral amygdala pathway 
plays a critical role in nicotine’s effect on the anxiety pathway expressed as changes in LES. 
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=================================== 
Insert Figure 5 about here 
=================================== 
 
Clinical Implications 
 The present findings also have important clinical implications. Taken together with other 
available research on long-term effects of nicotine, a general consensus emerges. Adolescent 
nicotine exposure is associated with long-term changes in the anxiety pathway and an increase in 
overall anxiety behavior, as well as increased risk of nicotine dependence (Slawecki et al., 2003; 
Smith et al., 2006; Trauth et al., 2000). In humans, McKenzie et al. (2010) found that adolescent 
“occasional smokers” who scored high on anxiety and depression scales were more likely to 
become addicted to nicotine in early adulthood. They further suggested that these adolescents 
and young adults use cigarettes to help alleviate depression and anxiety symptoms. There is also 
evidence that adolescents are more vulnerable to the effects of stress. In animal studies, 
adolescent rats are more likely to display anxiety-like behavior when exposed to stressors 
(Slawecki et al. 2005) and the adolescent period itself is recognized as a unique period of 
psychosocial stress in humans (Spear, 2000). Given the “self-medication” hypothesis suggested 
by McKenzie et al. (2010) adolescents may be more apt to turn to nicotine to relieve their stress. 
Individuals who begin smoking in adolescence may thus be particularly vulnerable to nicotine in 
adulthood, as (and perhaps particularly when) they are exposed to novel stressors. In sum, the 
suggestion here is that adolescent nicotine may increase adult anxiety. As a result, adolescents 
exposed to nicotine may be especially vulnerable to perceived stress-reducing effects of nicotine 
which then perpetuates continued drug use progressing to addiction (as illustrated in Figure 5).  
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Continued research that clarifies the effects of nicotine on the anxiety pathway may be an 
essential step toward breaking escalating patterns of drug use in vulnerable populations. 
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TABLE	  1	  
	  
Existing	  literature	  concerning	  effects	  of	  nicotine	  exposure	  on	  anxiety	  in	  males	  and	  females.	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Figure	  Captions	  	  	  
Figure	  1.	  Light-­‐enhanced	  startle	  chamber.	  	  
Figure	  2.	  Mean	  raw	  peak	  startle	  during	  Phase	  1	  and	  Phase	  2	  during	  the	  light-­‐enhanced	  startle	  test.	  Phase	  1	  and	  Phase	  2	  means	  are	  shown	  averaged	  across	  all	  other	  variables	  (dB	  amplitude,	  drug	  dose,	  sex).	  	  The	  overall	  difference	  score	  (Phase	  2	  mean	  –	  Phase	  1	  mean)	  is	  also	  shown.	  	  Brackets	  represent	  standard	  errors.	  	  
Figure	  3.	  Mean	  difference	  score	  (Phase	  2	  mean	  –	  Phase	  1	  mean)	  for	  males	  during	  the	  light-­‐enhanced	  startle	  test	  as	  a	  function	  of	  dB	  amplitude	  and	  adolescent	  nicotine	  exposure	  condition.	  Brackets	  represent	  standard	  errors.	  	  
Figure	  4.	  Mean	  difference	  score	  (Phase	  2	  mean	  –	  Phase	  1	  mean)	  for	  males	  during	  the	  light-­‐enhanced	  startle	  test	  as	  a	  function	  of	  dB	  amplitude	  and	  adolescent	  nicotine	  exposure	  condition.	  Brackets	  represent	  standard	  errors.	  	  
Figure	  5.	  Conceptual	  Model	  Illustrating	  How	  Adolescence,	  Nicotine	  and	  Anxiety	  Contribute	  to	  
Addiction.	  Anxiety	  problems	  in	  adolescents	  can	  lead	  to	  nicotine	  self-­‐medication,	  which	  may	  in	  turn	  lead	  to	  increased	  anxiety,	  as	  evidenced	  by	  the	  current	  findings.	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FIGURE	  1.	  	  Light-­‐enhanced	  startle	  chamber.	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FIGURE	  2.	  	  Raw	  Peak	  startle	  illustrating	  the	  basic	  light-­‐enhanced	  startle	  effect	  on	  the	  test	  day.	  The	  overall	  difference	  score	  (Phase	  3	  mean	  –	  Phase	  1	  mean)	  is	  also	  shown.	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FIGURE	  3.	  	  Light-­‐enhanced	  startle	  in	  adult	  males	  on	  the	  test	  day	  following	  adolescent	  nicotine	  exposure.	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FIGURE	  4.	  	  Light-­‐enhanced	  startle	  in	  adult	  females	  on	  the	  test	  day	  following	  adolescent	  nicotine	  exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0	  
20	  
40	  
60	  
80	  
100	  
120	  
140	  
160	  
180	  
100	   105	   115	  
D
IF
FE
RE
N
CE
	  S
CO
RE
	  
STARTLE	  	  PULSE	  AMPLITUDE	  (dB)	  
LES	  Anxiety:	  Females	  
saline	  
.15	  mg/kg	  
.40	  mg/kg	  
ADOLESCENT	  NICOTINE	  AND	  ANXIETY	  	  28	  	  
FIGURE	  5.	  Anxiety	  symptoms	  in	  adolescents	  can	  cause	  nicotine	  self-­‐medication	  and	  escalating	  nicotine	  use.	  	  
	  
	  
	  
	  
	  
	  
	  
